IRESS is down a lot, today, given the 2H skew required to hit guidance.

Here’s the update. $80M 1H, at midpoint of guidance requires $100/$180 = c55% 2H to meet.

However (and here we switch between NPAT and EPS, which isn’t perfect) the usual skew is 52%.

On it’s own, I wouldn’t have thought it worth -10%.

Also the 1H vs 2H uplift isn’t usually such an issue, given the history of growth, on whatever measure you prefer to look at.

But the CEO is also retiring.

The CEO retiring is well, anything you want it to be, depending on your view. Can be good, bad, or indifferent. The reality is the CEO shouldn’t make a huge difference, certainly not in the order of 10% of the market cap. But shouldn’t and doesn’t are two different things.

Going out on an upgrade perhaps, would be more universally acceptable. That would remove any ambiguity about future operational performance. Here, the fear is a high hurdle (the 2H stretch) that a new CEO won’t want to accept responsibility for, won’t want to accept culpability for, if missed.

As such, it is plausible (at least picturable) that they downgrade, and hence the market prices that prospect in, immediately.

In any case, we aren’t set to do anything. It’s a good company, it has pricing power, attractive in the current inflationary environment, and isn’t otherwise heavily linked to the economic cycle, and we don’t have any real reason to alter our thesis, or it’s likelihood of playing out.

Anytime uncertainty goes up, but our other estimates don’t change (for example, our long run view about the company) we tend to hold, neither buying nor selling more, relative to the position we already have.

We’ll wait for the result, see what new management has to say, and go from there.

Important Information: This document has been prepared by Aequitas Investment Partners ABN 92 644 165 266 (“Aequitas”, “our”, “we”), a Corporate Authorised Representative (no. 1284389) of C2 Financial Services, (Australian Financial Services Licensee no. 502171), and is for distribution within Australia to wholesale clients and financial advisers only.

This document is based on information available at the time of publishing, information which we believe is correct and any opinions, conclusions or forecasts are reasonably held or made as at the time of its compilation, but no warranty is made as to its accuracy, reliability or completeness. To the extent permitted by law, neither Aequitas nor any of its affiliates accept liability to any person for loss or damage arising from the use of the information herein.

Please note that past performance is not a reliable indicator of future performance.

General Advice Warning: This document has been prepared without taking into account your objectives, financial situation or needs, and therefore you should consider its appropriateness, having regard to your objectives, financial situation and needs. Before making any decision about whether to acquire a financial product, you should obtain and read the relevant Product Disclosure Statement (PDS) or Investor Directed Portfolio Service Guide (IDPS Guide) and consider talking to a financial adviser.

Taxation warning: Any taxation considerations are general and based on present taxation laws and may be subject to change. Aequitas is not a registered tax (financial) adviser under the Tax Agent Services Act 2009 and investors should seek tax advice from a registered tax agent or a registered tax (financial) adviser if they intend to rely on this information to satisfy the liabilities or obligations or claim entitlements that arise, or could arise, under a taxation law.

Receive our investment insights

Something went wrong. Please check your entries and try again.